Northwest Indiana Center for Clinical Research

Valparaiso, Indiana 46383

0 studies enrolling now · 16 studies all time

What they study most

Arthritis, Chronic Low Back Pain, Chronic Nonmalignant and Nonneuropathic Pain, Diabetes Mellitus, Type 2, Genotype 1 Chronic Hepatitis C, Low Back Pain, Major Depressive Disorder, Obesity, Osteoarthritis, Osteoarthritis, Hip, Osteoarthritis, Knee, Overweight

Studies at this site

• SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study — Stopped early
• Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder — Completed
• Tanezumab In Osteoarthritis Of The Hip Or Knee — Stopped early
• Tanezumab In Osteoarthritis Of The Knee (2) — Completed
• Extension Study Of Tanezumab In Osteoarthritis — Stopped early
• Tanezumab in Osteoarthritis of the Knee — Completed
• Tanezumab in Osteoarthritis Of The Hip — Completed
• Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period. — Completed
• Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain — Completed
• Add-on to Thiazolidinedione (TZD) Failures — Completed
• Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain — Completed
• A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone — Completed
• A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects — Completed
• A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes — Completed
• Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection — Completed
• Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis (OA) of the Knee — Completed